Evaluation of cervical nodal necrosis in nasopharyngeal carcinoma by computed tomography: Incidence and prognostic significance

Head and Neck

Volumn 19, Issue 4, 1997, Pages 266-275

  Chua, Daniel T T ^a   Sham, Jonathan S T ^a   Kwong, Dora L W ^a   Choy, Damon T K ^a   Leong, Lilian ^b   Chan, F L ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Chemotherapy; Computed tomography; Nasopharyngeal carcinoma; Nodal necrosis; Radiotherapy

Indexed keywords

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER SURVIVAL; CELL KINETICS; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; INCIDENCE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; NECROSIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; ANALYSIS OF VARIANCE; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NECROSIS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030955654     PISSN: 01486403     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Sham JST, Choy D. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br J Radiol 1990;63: 51-58.
2. Fandi A, Altun M, Azli N, Armand JP, Cvitkovic E. Nasopharyngeal cancer: epidemiology, staging and treatment. Sem Oncol 1994;21:382-397.
3. Teo P, Shiu W, Leung SF, Lee WY. Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography - an analysis of 659 patients. Radiother Oncol 1992;23:79-93.
4. Neel HB, Taylor WF. New staging system for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1989;115:1293-1303.
5. Tang SGJ, Lin FJ, Chen MS, Liaw CC, Leung WM, Hong JH. Prognostic factors of nasopharyngeal carcinoma: a multivariate analysis. Int J Radiat Oncol Biol Phys 1090;19:1143-1149.
6. Lee AWM, Poon YF, Foo W, et al. Retrospective analysis of 5307 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992;23:261-270.
7. Sham JST, Choy D. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival. Head Neck 1991;13:298-310.
8. Perez CA, Devineni VR, Marcial-Vega V, Marks JE, Simpson JR, Kucik N. Carcinoma of nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992;23: 271-280.
9. Sham ST, Cheung YK, Choy D, Chan FL, Leong L. Computed tomography evaluation of neck node metastases from nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1993;26:787-792.
10. Munck JN, Cvitkovic E, Piekarski JD, et al. Computed tomographic density of metastatic lymph nodes as a treatment-related prognostic factor in advanced head and neck cancer. J Natl Cancer Inst 1991;83:569-575.
11. Ho JHC. Stage classification for malignant tumors of the pharynx. Presented at the Asian Pacific Cancer Congress 1993, Thailand.
12. Mancuso AA, Harnsberger HR, Muraki AS, Stevens MH. Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal, and application in staging head and neck cancer, Part II: Pathology, Radiology 1983;148:715-723.
13. Som PM. Lymph nodes of the neck. Radiology 1987;165: 593-600.
14. Ho JHC. Nasopharynx. In: Halnan KE, ed. Treatment of cancer. London: Chapman and Hall, 1982:249-267.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
16. Cox DR. Regression models and life-tables. J R Stat Soc (B) 1972;34:187-202.
17. Janot F, Cvitkovic E, Piekarski JD, et al. Correlation between nodal density in contrasted scans and response to cisplatin-based chemotherapy in head and neck squamous cell carcinoma: a prospective validation. Head Neck 1993;15:222-229.
18. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
19. Vanpel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply and metabolic microenvironment of human tumors: a review. Cancer Res 1989;46:6449-6465.
20. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955;9:539-549.
21. Vaupel PW. Oxygenation of solid tumors. In: Teicher BA, ed. Drug resistance in oncology. New York: Marcel Dekker Inc, 1993:59-85.
22. Gatenby RA, Kessler HB, Rosenblum JS, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy, Int J Radiat Oncol Biol Phys 1988;14:831-838.
23. Gray LH, Conger AD, Ebert M et al. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953;26:638-648.
24. Hill RP. Tumor progression: potential role of unstable genomic changes. Cancer Metastasis Rev 1991;9:137-147.
25. Luk CK, Veinot-Drebot L, Tjan E, Tannock IF. Effect of transient hypoxia on sensitivity to doxorubicin in human and murin cell lines. J Natl Cancer Inst 1990;82:684-692.
26. Young SD, Marshall RS, Hill RP. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA 1988;85: 9533-9537.
27. Rice GC, Ling V, Schimke RT. Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (adriamycin) resistance. Proc Natl Acad Sci USA 1987;84:9261-9264.
28. Young SD, Hill RP. Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. J Natl Cancer Inst 1990;82: 338-339.
29. Brown JM, Sum BG. Hypoxia-specific cytotoxins in cancer therapy. Sem Radiat Oncol 1996;6:10-21.
30. Brown JM. Hypoxic cell radiosensitisers: the end of an era? Int J Radiat Oncol Biol Phys 1995;32:883-885.
31. Overgaard J, Horsman MR. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Sem Radiat Oncol 1996;6:10-21.
32. Nordsmark M, Bentzen SM, Overgaard J. Measurement of human tumor oxygenation status by a polarographic needle electrode: an analysis of inter- and intratumour heterogeneity. Acta Oncol 1994;33:383-389.
33. Jin GY, Li SJ, Moulder JE, Raleigh JA. Dynamic measurements of hexafluoromisonidazole (CCI-103F) retention in mouse tumors by 1H/19F magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 1990;58: 1025-1034.
34. Groshar D, McEwan AJ, Parliament MB et al. Imaging tumor hypoxia and tumor perfusion. J Nucl Med 1993;34: 885-888.
35. Fairbarin DW, Olive PL, O'Neill KL. The comet assay: a comprehensive review. Mutat Res 1995;339:37-59.
36. Fenton BM, Rofstad EK, Degner FL, Sutherland RM. Cryospectrophotometric determination of tumor intravascular oxyhemoglobin saturations: dependence on vascular geometry and tumor growth. J Natl Cancer Inst 1988;80: 1612-1619.